Phacoemulsification and intraocular lens implantation after inadvertent intracapsular injection of intravitreal dexamethasone implant

BMJ Case Reports

Volumn , Issue , 2012, Pages

  Ram, Jagat ^a   Agarwal, Aniruddha Kishandutt ^a   Gupta, Adit ^a   Gupta, Amod ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPLEGIC AGENT; DEXAMETHASONE; METHOTREXATE; STEROID;

ADULT; AGED; ARTICLE; CASE REPORT; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; EYE LAVAGE; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; HYDRODELINEATION; HYDRODISSECTION; HYDROPHOBICITY; INTRAOCULAR PRESSURE; JUVENILE RHEUMATOID ARTHRITIS; LENS CAPSULE RUPTURE; LENS IMPLANT; MACULAR THICKNESS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTICAL COHERENCE TOMOGRAPHY; PHACOEMULSIFICATION; PRIORITY JOURNAL; TREATMENT RESPONSE; UVEITIS; VISUAL ACUITY; VITRECTOMY;

EID: 84872574860     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2012-007494     Document Type: Article

References (16)

1. Peyman GA, Lad EM, Moshfeghi DM. Intravitreal injection of therapeutic agents. Retina 2009;29:875-912.
2. Patelli F, Fasolino G, Radice P, et al. Time course of changes in retinal thickness and visual acuity after intravitreal triamcinolone acetonide for diffuse diabetic macular edema with and without previous macular laser treatment. Retina 2005;25:840-5. (Pubitemid 41456573)
3. Kuppermann BD, Blumenkranz MS, Haller JA, et al. Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol 2007;125:309-17. (Pubitemid 46425557)
4. Haller JA, Bandello F, Belfort R Jr, et al. OZURDEX GENEVA Study Group. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010;117:1134-46.
5. Haller J, Kuppermann BD, Blumenkranz MS, et al. Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch Ophthalmol 2010;128:289-96.
6. Lowder C, Belfort R, Lightman S, et al. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol 2011;129:545-53.
7. Jager RD, Aeillo LP, Patel SC, et al. Risks of intravitreous injection: A comprehensive review. Retina 2004;24:676-98. (Pubitemid 39391758)
8. Aeillo LP, Brucker AJ, Chang SC, et al. Evolving guidelines for intravitreous injections. Retina 2004;24:S3-19.
9. Hattenbach LO, Klais C, Koch FH, et al. Intravitreous injection of tissue plasminogen activator and gas in treatment of submacular hemorrhage under various conditions. Ophthalmology 2001;108:1485-92. (Pubitemid 32709042)
10. Moshfegi DM, Kaiser PK, Scott IU, et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003;136:791-6. (Pubitemid 37330020)
11. The Eyetech Study Group. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration. Retina 2002;22:143-52.
12. The Eyetech Study Group. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results. Ophthalmology 2003;110:979-86.
13. Eckardt C. Transconjunctival sutureless 23-gauge vitrectomy. Retina 2005;25:208-11. (Pubitemid 40365946)
14. Leydolt C, Findl O, Drexler W. Effects of change in intraocular pressure on axial eye length and lens position. Eye 2007;22:657-61.
15. Sen HN, Drve LT, Goldstein DA. Multicentre Uveitis Steroid Treatment (MUST) Trial Research Group. Hypotony in uveitis patients. Ocul Immunol Inflamm 2012;20:104-12.
16. Lam AKC, Chen D. Effect of ocular massage on intraocular pressure and corneal biomechanics. Eye 2007;21:1245-46. (Pubitemid 47382161)